| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/02/2004 | WO2004073748A1 Aqueous suspension medicine |
| 09/02/2004 | WO2004073747A1 Orally administrable pharmaceutical compositions and methods for preventing food-dr ug interaction |
| 09/02/2004 | WO2004073746A1 Use of 2-hydroxymethyltetrahydropyran as excipient in a pharmaceutical or cosmetic composition |
| 09/02/2004 | WO2004073745A1 Salicylic acid derivative as efficacy enhancer and method |
| 09/02/2004 | WO2004073744A1 Seamless capsule |
| 09/02/2004 | WO2004073743A2 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions |
| 09/02/2004 | WO2004073739A1 A method of diagnosis and treatment |
| 09/02/2004 | WO2004073738A2 Composition to be administered to a living being and method for marking agents |
| 09/02/2004 | WO2004073713A1 Pirfenidone gel preparation |
| 09/02/2004 | WO2004073707A1 Topical composition containing alkyl gallate or alkyl hydroxybenzoate or phenol alkyloxy as agent against acne |
| 09/02/2004 | WO2004073696A1 Uv stable transdermal therapeutic plaster |
| 09/02/2004 | WO2004073692A1 Hard capsule of hardly water-soluble drug |
| 09/02/2004 | WO2004073680A1 Ointment of droplet-dispersion type |
| 09/02/2004 | WO2004073677A1 Therapeutic agent angiogen |
| 09/02/2004 | WO2004073659A2 HIV gp120 MIMOTOPE ANTIGEN |
| 09/02/2004 | WO2004073656A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/02/2004 | WO2004073654A2 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| 09/02/2004 | WO2004073652A2 Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination |
| 09/02/2004 | WO2004073648A2 Composition and methods for inhibiting cell survival |
| 09/02/2004 | WO2004073643A2 Estradiol metabolites for the treatment of pulmonary hypertension |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004073597A2 Bioadhesive liquid composition which is substancially free of water |
| 09/02/2004 | WO2004062569A3 Cardiolipin compositions their methods of preparation and use |
| 09/02/2004 | WO2004054600B1 Pharmaceutical compound containing silymarin and carbopol®, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 09/02/2004 | WO2004050710A3 Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups |
| 09/02/2004 | WO2004050057A3 An exopolysaccharides delivery system for active molecules |
| 09/02/2004 | WO2004047791A3 Emulsive water-soluble concentrates |
| 09/02/2004 | WO2004046730A3 Uses of ble proteins and antibiotics from the bleomycin family |
| 09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |
| 09/02/2004 | WO2004043375A3 Pharmaceutical compositions and methods of using taxane derivatives |
| 09/02/2004 | WO2004037187A3 Metal-containing materials, compositions and methods |
| 09/02/2004 | WO2004022657A3 Increasing of the resorption of substances via skin and mucous membranes |
| 09/02/2004 | WO2004018000A3 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents |
| 09/02/2004 | WO2003087156A3 Heterogeneous crosslinked protein networks and methods for producing them |
| 09/02/2004 | WO2003086312A3 Conjugates comprising cancer cell specific ligands, a sugar and cancer chemotherapeutic agents/boron neutron capture therapy agents, and uses thereof |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | WO2003077867A3 Naltrexone hydrochloride compositions |
| 09/02/2004 | WO2003063910A3 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 09/02/2004 | WO2003032906A3 Delivery of poorly soluble drugs |
| 09/02/2004 | WO2003026617A8 (ester)-lysolecithins in liposomes |
| 09/02/2004 | US20040171992 Cream dispenser providing sequential dispensing means |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171795 capable of binding to a gene and transferring this gene into cells, have an affinity with phosphatidylserine, have a high safety and an excellent selectivity; for gene therapy/cancer treatment; genetic engineering |
| 09/02/2004 | US20040171691 Propofol with cysteine |
| 09/02/2004 | US20040171684 Shelf stable verapamil hydrochloride formulations including carrier, antioxidant and chelant |
| 09/02/2004 | US20040171669 Rapid disintegration on contact with saliva forming easy to swallow palatable suspension; tablets |
| 09/02/2004 | US20040171646 Novel substituted benzimidazole dosage forms and method of using same |
| 09/02/2004 | US20040171625 transdermal formulations comprise a skin penetration enhancer; transdermal formulation, which is topically applied to an area of skin superficial to a carotid artery, a temporal artery, a vertebral artery, or to a tender spot associated with a head |
| 09/02/2004 | US20040171613 Therapeutic agent for non-immediate type allergic diseases |
| 09/02/2004 | US20040171599 Use of a pharmaceutically acceptable cellulose derivative to inhibit or reduce crystal growth of ascomycin |
| 09/02/2004 | US20040171584 formulations of ANGIOTENSIN II AT1 receptors antagonists, using the cyclodextrins or their derivatives, lipossomes and the biodegradable polymers; increasing the bio-availability of losartan |
| 09/02/2004 | US20040171581 Polysaccharidic esters of retinoic acid |
| 09/02/2004 | US20040171580 Regioselectively reticulated polysaccharides |
| 09/02/2004 | US20040171572 Complex cationic lipids having quaternary nitrogens therein |
| 09/02/2004 | US20040171562 covalently forming prodrug by linking oligopeptide cleavable by plasmin to a stabilizing group and directly or indirectly linking the therapeutic agent at a second attachment site to oligopeptide; decreasing the toxicity of a therapeutic agent |
| 09/02/2004 | US20040171561 storage-stable mixture of a benzoyl peroxide dispersion, clindamycin or a pharmaceutically acceptable salt or ester thereof, and a pharmaceutically acceptable carrier |
| 09/02/2004 | US20040171560 antineoplastic agents such as paclitaxel, teniposide, camptothecin and derivatives thereof; preferred solvent includes absolute or dehydrated alcohol |
| 09/02/2004 | US20040171550 inhalation of the powder from an inhaler device which dispenses the correct dose of powdered polypeptide/enhancer in a particle size which maximizes deposition in the lower respiratory tract |
| 09/02/2004 | US20040171545 Plastic and elastic protein copolymers |
| 09/02/2004 | US20040171542 T1249 is a member of a new class of antiviral agents that inhibit virus/membrane fusion |
| 09/02/2004 | US20040171531 Non-aqueous injectable formulations for extended release of somatotropin |
| 09/02/2004 | US20040171524 Glycoconjugate that is enzyme conjugated to carbohydrate which binds to a lectin |
| 09/02/2004 | US20040171521 Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| 09/02/2004 | US20040171518 Compounds for protein stabilization and methods for their use |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171103 Process for the production of a reversibly inactive acidified plasmin composition |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170750 Edible composition and dosage form comprising an edible shell |
| 09/02/2004 | US20040170712 Applying a Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170711 Medical effect of Jojoba oil in the treatment of anal diseases |
| 09/02/2004 | US20040170710 Treating vaginal diseases by applying Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170695 Melt granulated composition and modified release dosage form prepared from said composition |
| 09/02/2004 | US20040170693 Microcapsules |
| 09/02/2004 | US20040170690 Tablet comprising cetirizine and pseudoephedrine |
| 09/02/2004 | US20040170684 For therapy of incontinence |
| 09/02/2004 | US20040170678 Liposomal antineoplastic drugs and uses thereof |
| 09/02/2004 | US20040170676 Mixture for transdermal delivery of low and high molecular weight compounds |
| 09/02/2004 | US20040170673 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 09/02/2004 | US20040170658 capable of absorbing up to at least twice its weight of water, obtained by hemi-synthesis from a mixture of unsaturated fatty acids, esters, unsaturated hydrocarbons or unsaturated derivatives and compounds with hydroxyl functions, preferably without a catalyst and in an atmosphere devoid of oxygen. |
| 09/02/2004 | US20040170651 In vivo modulation of neuronal transport |
| 09/02/2004 | US20040170650 Pharmaceutical compositions having a modified vehicle |
| 09/02/2004 | US20040170641 Prevention and treatment of amyloidogenic disease |
| 09/02/2004 | US20040170640 Methods for preparing and delivering adjuvant compositions |
| 09/02/2004 | US20040170632 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/02/2004 | US20040170623 having a concentration of at least 50 mg/ml of the antibody and containing an acidic component; nasal sprays and slow release formulations drying or freeze-drying |
| 09/02/2004 | US20040170618 antagonists bind to a recognized target (e.g., a receptor); the enzyme component of the chimera then degrades the target resulting in a reduction of activity of the target and release of the chimeric molecule, which is then free to attack and degrade another target molecule. |
| 09/02/2004 | US20040170595 Multi-arm block copolymers as drug delivery vehicles |
| 09/02/2004 | US20040170588 Polyethersiloxane copolymer in aqueous solution |
| 09/02/2004 | US20040170573 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 09/02/2004 | US20040170572 Delivery of rizatriptan or zolmitriptan through an inhalation route |
| 09/02/2004 | US20040170570 Delivery of rizatriptan or zolmitriptan through an inhalation route |
| 09/02/2004 | US20040170569 Dosage forms that rapidly produces peak plasma concentrations; heating a thin layer of the drug on a solid support to form a vapor; and passing air through the heated vapor to produce aerosol particles having less than 10% drug degradation products |
| 09/02/2004 | US20040170568 Stabilized preparations for use in metered dose inhalers |
| 09/02/2004 | US20040170560 Liposome confining prodrug, radioactive materials; multilayer; storage stability; antiinflammatory agents; infection therapy; antitumor agents imaging for diagnosis |
| 09/02/2004 | US20040169298 Microcapsule and production method thereof |
| 09/02/2004 | DE202004005692U1 Heil- und Wundsalbe auf der Basis einer wässrigen Emulsion Healing and antiseptic ointment based on an aqueous emulsion |
| 09/02/2004 | DE10025971B4 Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung Transdermal therapeutic system in Plasterform with reduced tendency to drug crystallization and its use |
| 09/02/2004 | CA2517005A1 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 09/02/2004 | CA2516453A1 Composition and methods for inhibiting cell survival |